SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
三度和弦
Lv3
220 积分
2023-11-27 加入
最近求助
最近应助
互助留言
Quantitative HBeAg is a strong predictor of HBeAg loss among patients receiving pegylated interferon
2个月前
已完结
Quantitative HBeAg is a strong predictor of HBeAg loss among patients receiving pegylated interferon
2个月前
已完结
Quantitative HBeAg is a strong predictor of HBeAg loss among patients receiving pegylated interferon
2个月前
已完结
Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)
3个月前
已完结
Tenofovir alafenamide versus entecavir for treating hepatitis B virus-related acute-on-chronic liver failure: real-world study
3个月前
已完结
Higher risk of kidney function decline with entecavir than tenofovir alafenamide in patients with chronic hepatitis B
3个月前
已完结
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
3个月前
已完结
Randomised clinical trial: 48 weeks of treatment with tenofovir amibufenamide versus tenofovir disoproxil fumarate for patients with chronic hepatitis B
4个月前
已完结
Effectiveness and safety of tenofovir amibufenamide and its comparison with tenofovir alafenamide in patients with chronic hepatitis B: results from a retrospective real-world study
4个月前
已完结
Multi-parametric analysis of human livers reveals variation in intrahepatic inflammation across phases of chronic hepatitis B infection
4个月前
已完结
没有进行任何应助
没有进行任何互助留言
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论